Hydroxyamphetamine / tropicamide
Dilation & diagnostic · Rx
RxDilation & diagnosticMydriatic Red cap
| Strength | Hydroxyamphetamine 1% + tropicamide 0.25% |
|---|---|
| Drug class | Combination mydriatic (adrenergic releaser + anticholinergic) |
| Mechanism of action | Hydroxyamphetamine releases endogenous norepinephrine onto the dilator muscle; tropicamide blocks the sphincter, rapid dilation with minimal cycloplegia and faster recovery than tropicamide + phenylephrine. |
| Indication / reason for use | Routine diagnostic mydriasis when quick recovery is desired. |
| Usual adult dosing | 1-2 drops; mydriasis within 15 min, recovery in a few hours. |
| Preservative | BAK |
| Contact lenses | Remove lenses; reinsert after 15 minutes. |
| Common / important adverse effects | Stinging, photophobia, mild transient blur; angle-closure risk in narrow angles. |
| Contraindications & cautions | Narrow angles; note hydroxyamphetamine invalidates a subsequent Horner localization test, don't use it if that work-up is planned. |
| Pregnancy / lactation | Limited data. |
| Pregnancy category (older labels) | Category C on the label (the FDA retired letter categories in 2015). From DailyMed labels, checked Nov 2026. |
| Trade names | Paremyd |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.